Airway Clearance Solutions Market Global Report 2026

The airway clearance solutions market size has grown rapidly in recent years. It will grow from $0.93 billion in 2025 to $1.06 billion in 2026 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to rising prevalence of chronic respiratory diseases, increasing geriatric population, growing awareness of respiratory care, expanding home healthcare services, improving access to respiratory therapy.

The airway clearance solutions market size is expected to see rapid growth in the next few years. It will grow to $1.81 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing demand for home-based respiratory management, growing burden of neuromuscular disorders, expanding healthcare infrastructure in emerging economies, rising focus on preventive respiratory care, increasing adoption of advanced airway clearance therapies. Major trends in the forecast period include increasing adoption of home-based airway clearance therapy, growing preference for portable and wearable airway clearance devices, rising integration of personalized respiratory therapy protocols, expanding use of non-invasive mucus clearance therapies, increasing demand for long-term respiratory disease management.

The increasing prevalence of chronic respiratory diseases is expected to drive the growth of the airway clearance solutions market going forward. Chronic respiratory diseases refer to long-term conditions that affect the airways and lungs, making breathing difficult and gradually reducing normal lung function over time. The growing prevalence of chronic respiratory diseases is attributed to increasing exposure to air pollution and tobacco smoke, as prolonged inhalation of harmful pollutants damages lung tissue, impairs respiratory function, and contributes to a higher occurrence of conditions such as COPD, asthma, and chronic bronchitis. Airway clearance solutions assist in loosening and removing accumulated mucus, improving airway patency, enhancing breathing efficiency, lowering the risk of respiratory infections and exacerbations, and supporting effective long-term disease management. For instance, in June 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 80 million people in the WHO European Region are living with chronic respiratory diseases, and chronic obstructive pulmonary disease (COPD) cases are expected to rise by 23% globally by 2050. Therefore, the increasing prevalence of chronic respiratory diseases is contributing to the growth of the airway clearance solutions market.

Leading companies operating in the airway clearance solutions market are focusing on developing advanced solutions, such as high-frequency chest wall oscillation (HFCWO) systems, to improve patient comfort, portability, and treatment effectiveness. High-frequency chest wall oscillation (HFCWO) systems are airway clearance devices that use rapid chest wall compressions to loosen and mobilize mucus in the lungs, helping patients effectively clear airway secretions associated with chronic respiratory conditions. For example, in September 2024, Baxter International Inc., a US-based medical technology company, launched the next generation of The Vest for Airway Clearance, the Vest Advanced Pulmonary Experience (APX) System, featuring an advanced digital touchscreen interface, enhanced patient comfort, improved portability, and unique garment design options. The system uses High Frequency Chest Wall Oscillation (HFCWO) technology to mobilize and clear mucus from the airways, supporting effective airway clearance therapy for adults and children with chronic lung conditions such as cystic fibrosis and bronchiectasis.

In September 2023, Inogen Inc., a US-based medical technology company focused on respiratory care solutions, acquired Physio-Assist SAS for $32 million. Through this acquisition, Inogen sought to broaden its respiratory care product portfolio by incorporating advanced airway clearance technologies, reinforce its position in the global respiratory healthcare market, and improve treatment solutions for individuals suffering from chronic respiratory conditions through innovative mucus management technologies. Physio-Assist SAS is a France-based medical device manufacturer specializing in airway clearance solutions, including the Simeox system designed for patients with bronchiectasis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD).

Major companies operating in the airway clearance solutions market report are Baxter International Inc., Tactile Medical, Electromed Inc., ICU Medical Inc., Monaghan Medical Corporation, Trudell Medical International, PARI GmbH, R. Cegla GmbH & Co. KG, AirPhysio Pty Ltd, GaleMed Corporation, Movair, Pulmodyne Inc., Thayer Medical Corporation, Flexicare Group Ltd., Mercury Medical, Intersurgical Ltd., Fanem Ltda., VORTRAN Medical Technology, Med Systems Inc., ABM Respiratory Care.

North America was the dominant region in the airway clearance solutions market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the airway clearance solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the airway clearance solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.